The Pfizer-BioNTech Covid-19 vaccine was 73 per cent effective in protecting children ages 6 months through 4 years during the time when the Omicron strain was highly prevalent, Pfizer has announced
The updated data showed 13 children had Covid, at least seven days after receiving a third dose of the Pfizer-BioNTech COVID-19 vaccine, compared with 21 cases among those who received a placebo
Albert Bourla said Monday that he started taking Pfizer's Paxlovid pill treatment and is isolating while he recovers
Over the past 14 years, Sridhar has led a number of key leadership positions in Pfizer, including serving as the Chief Financial Officer for a period of eight years
The so-called bivalent vaccine targets two strains of the SARS-CoV-2 virus behind COVID
Pfizer has been on the lookout for acquisitions that could bring in billions in annual sales by the end of the decade
Pfizer also announced in April a smaller acquisition to buy the privately held ReViral Ltd., which is developing a treatment for respiratory syncytial virus
The drug firm said exceptional items for June quarter comprised Rs 130 crore on account of a voluntary retirement scheme and Rs 6 crore for restructuring to drive business transformation.
Stocks to Watch: With oil prices staging a dramatic reversal, related stocks, along with rate-sensitive sectors will be on the radar as RBI announces its monetary policy outcome Friday.
Stocks to Watch today: Cigarettes-to-hotels major ITC on Monday reported a 33.98 per cent year-on-year (YoY) jump in its consolidated net profit, which came in at Rs 4,389.76 crore
'Given his rebound positivity which we reported yesterday, we continued daily monitoring. This morning, unsurprisingly, his SARS-CoV-2 antigen testing remained positive,' the physician said
US President Joe Biden, who first tested positive for Covid-19 on July 21, before receiving his negative testing results, earlier this week, has tested positive again in a "rebound" case
Researchers noted that the widely available Covid-19 vaccinations keeping the majority of the population free from serious illness will not be enough to stop the spread of the virus and its variants.
Moderna said its decision to develop the bivalent vaccines was based on different market preferences for shots against the subvariants.
The US government on Sunday delivered 33,600 doses of Pfizer's pediatric COVID-19 vaccine to Bhutan. The US embassy in India said the vaccine doses were supplied as part of President Joe Biden's commitment to helping countries around the world to deal with the pandemic. It said these "safe and effective" pediatric vaccine doses will protect the lives of children in Bhutan and help stop the spread of COVID-19. "As part of President Biden's commitment to donate COVID-19 vaccine doses to countries around the world, the US government has delivered 33,600 doses of the Pfizer pediatric COVID-19 vaccine to Bhutan, in partnership with COVAX and the Bhutan Foundation," it said in a statement. USAID's Mission Director to India and Bhutan Veena Reddy said, "The US is committed to a global COVID-19 response because it makes us all stronger and safer -- Americans and Bhutanese alike." "The USAID is proud to work with the Royal Government of Bhutan and our partner, the Bhutan Foundation, to del
Use of the pill which is now authorized to treat newly infected, at-risk people to prevent severe illness, has however jumped in recent weeks as infections rise
A booster dose of the Omicron-adapted bivalent candidates conferred a 9.1 and 10.9-fold increase in neutralising antibodies against Omicron BA.1, that was circulating last winter
While more than 7 million deaths were likely averted in countries covered by Covax, the WHO-backed distribution program, the research nonetheless highlights the devastation caused by uneven access
Pfizer's is already authorized for those over the age of 5
The US Food and Drug Administration (FDA) said that kid-sized doses of Pfizer-BioNTech's COVID-19 vaccine appear to be safe and effective for children under 5-years-old